Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.78 USD | -5.97% | -1.56% | +603.91% |
May. 31 | Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target | MT |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+603.91% | 207M | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.28% | 22.48B | |
-9.88% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Wedbush Cuts Elevation Oncology's Price Target to $21 From $27, Citing 'Financing Environment;' Outperform Rating Kept